BMH 21
Tocris Bioscience, part of Bio-Techne | Catalog # 5417
RNA polymerase I inhibitor; also p53 pathway activator
Key Product Details
Description
RNA polymerase I inhibitor; also p53 pathway activator
Product Description
BMH 21 is a p53 pathway activator; induces expression of p53 target genes. Also RNA polymerase 1 inhibitor; promotes degradation of RPA194. Reduces viability of multiple tumor cell lines and attenuates tumor growth of A375 melanoma cell xenografts in mice.Product Specifications
Molecular Weight
360.41
Formula
C21H20N4O2
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
N-[2-(Dimethylamino)ethyl]-12-oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide
CAS Number
896705-16-1
PubChem ID
3508054
InChI Key
BXYDVWIAGDJBEC-UHFFFAOYSA-N
SMILES
O=C2N4C(C(C(NCCN(C)C)=O)=CC=C4)=NC(C2=C3)=CC1=C3C=CC=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 1.8 | 5 with gentle warming |
Preparing Stock Solutions
for BMH 21
The following data is based on the product molecular weight 360.41
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.05 mM | 55.49 mL | 277.46 mL | 554.92 mL |
| 0.25 mM | 11.10 mL | 55.49 mL | 110.98 mL |
| 0.5 mM | 5.55 mL | 27.75 mL | 55.49 mL |
| 2.5 mM | 1.11 mL | 5.55 mL | 11.10 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Colis Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors. J.Med.Chem. 2014 PMID: 24847734
- Peltonen Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents. PLoS ONE 2010 PMID: 20885994
- Peltonen A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 2014 PMID: 24434211
Product Specific Notices for BMH 21
For research use only
Loading...
Loading...